in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Generic Drug Fees: A Fantastic Oppprtunity
7:13 AM MDT | September 1, 2011 | Girish Malhotra
The U.S. FDA has created a fantastic opportunity for incorporating the best manufacturing technologies in the pharmaceutical hemisphere by charging fees to every generic company globally. The carrot of early approval - if that happens - will be a driver to have the best processes for active pharmaceutical ingredient (API) and formulation if the companies want to produce repeatable quality and safe drugs. Early approvals also will mean quicker profits compared to the current status. It would be a win-win. Early approval will require that processes meet the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee